GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calidi Biotherapeutics Inc (AMEX:CLDI) » Definitions » Accumulated other comprehensive income (loss)

Calidi Biotherapeutics (Calidi Biotherapeutics) Accumulated other comprehensive income (loss) : $0.01 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Calidi Biotherapeutics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Calidi Biotherapeutics's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was $0.01 Mil.

Calidi Biotherapeutics's quarterly Accumulated other comprehensive income (loss) declined from Sep. 2023 ($-0.00 Mil) to Dec. 2023 ($-0.05 Mil) but then increased from Dec. 2023 ($-0.05 Mil) to Mar. 2024 ($0.01 Mil).

Calidi Biotherapeutics's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 ($-0.00 Mil) to Dec. 2022 ($-0.01 Mil) and declined from Dec. 2022 ($-0.01 Mil) to Dec. 2023 ($-0.05 Mil).

Calidi Biotherapeutics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Calidi Biotherapeutics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calidi Biotherapeutics Accumulated other comprehensive income (loss) Chart

Calidi Biotherapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
0.01 - -0.01 -0.05

Calidi Biotherapeutics Quarterly Data
Dec20 Sep21 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.02 - -0.05 0.01

Calidi Biotherapeutics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Calidi Biotherapeutics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Calidi Biotherapeutics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Calidi Biotherapeutics (Calidi Biotherapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calidi Biotherapeutics Inc (AMEX:CLDI) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
LIFE AVRO GTHX OMER ORMP ELYM MDWD STTK CTMX CAPR OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
11011 North Torrey Pines Road, Suite 200, La Jolla, CA, USA, 92037
Website
https://www.calidibio.com
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.

Calidi Biotherapeutics (Calidi Biotherapeutics) Headlines

From GuruFocus

Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV

By ACCESSWIRE • 05-17-2024